Wide Ranks

MEDP

Medpace Holdings, Inc.

338.96

Top Statistics
Market Cap 10 B Forward PE 26.19 Revenue Growth 8.30 %
Current Ratio 0.99 Trailing PE 29.68 Earnings Growth 35.60 %
Profit Margins 17.66 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 22.87 Enterprise / Revenue 4.83 Price To Sales Trailing12 Months 5.09
Profitability
Profit Margins 17.66 % Operating Margins 21.05 %
Balance Sheet
Total Cash 656 M Total Cash Per Share 21.18 Total Debt 151 M
Total Debt To Equity 17.23 Current Ratio 0.99 Book Value Per Share 28.42
All Measures
Short Ratio 271.00 % Message Board Id finmb_260345878 Fax 513 579 0444
Shares Short Prior Month 1 M Return On Equity 0.5408 City Cincinnati
Uuid b158a4ab-e72e-3133-a90d-5be125173518 Previous Close 335.21 First Trade Date Epoch Utc 1 B
Book Value 28.42 Beta 1.37 Total Debt 151 M
Volume 183510 Price To Book 11.93 Fifty Two Week Low 268.80
Total Cash Per Share 21.18 Total Revenue 2 B Shares Short Previous Month Date 1 B
Target Median Price 348.50 Max Age 86400 Recommendation Mean 2.36
Sand P52 Week Change 0.3133 Operating Margins 21.05 % Target Mean Price 347.92
Net Income To Common 365 M Short Percent Of Float 0.0549 Implied Shares Outstanding 31 M
Trailing Peg Ratio 161.24 % Last Fiscal Year End 1 B Average Daily Volume10 Day 441780
Average Volume10days 441780 Total Cash 656 M Next Fiscal Year End 1 B
Revenue Per Share 67.02 Held Percent Insiders 0.1778 Ebitda Margins 21.13 %
Trailing PE 29.68 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 335.21 Target Low Price 296.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 338.92 Open 335.91 Free Cashflow 437 M
State OH Dividend Yield 0.00 % Return On Assets 0.1431
Time Zone Short Name EST Trailing Eps 11.42 Day Low 333.50
Address1 5375 Medpace Way Shares Outstanding 31 M Price Hint 2
Target High Price 400.00 Website https://www.medpace.com 52 Week Change 0.2521
Average Volume 395750 Earnings Quarterly Growth 36.70 % Forward Eps 12.49
Recommendation Key buy Compensation As Of Epoch Date 1 B Quick Ratio 93.00 %
Is_sp_500 False Regular Market Day High 341.27 Profit Margins 17.66 %
Debt To Equity 17.23 Fifty Two Week High 459.77 Day High 341.27
Shares Short 1 M Regular Market Open 335.91 Industry Key diagnostics-research
Earnings Growth 35.60 % Enterprise To Revenue 4.83 Revenue Growth 8.30 %
Shares Percent Shares Out 0.0366 Operating Cashflow 574 M Currency USD
Time Zone Full Name America/New_York Market Cap 10 B Is_nasdaq_100 False
Zip 45227 Quote Type EQUITY Industry Diagnostics & Research
Long Name Medpace Holdings, Inc. Regular Market Day Low 333.50 Held Percent Institutions 0.8595
Current Price 338.96 Enterprise To Ebitda 22.87 Financial Currency USD
Current Ratio 0.99 Gross Margins 67.22 % Industry Disp Diagnostics & Research
Number Of Analyst Opinions 10 Country United States Float Shares 25 M
Two Hundred Day Average 379.31 Enterprise Value 10 B Price To Sales Trailing12 Months 5.09
Forward PE 26.19 Regular Market Volume 183510 Ebitda 437 M
Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas.

It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services.

In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials.

Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.